Key result
Transcatheter closure of ASD with a modified fenestrated Amplatzer septal occluder in 3 elderly patients resulted in a trace or small fenestration without hemodynamic significance at 4-18 months.
Why the study?
Does transcatheter closure with a fenestrated septal occluder improve hemodynamics and symptoms in elderly patients with ASD and restrictive LV physiology or pulmonary hypertension?
Case Report (n=3)
Does transcatheter closure with a fenestrated septal occluder improve hemodynamics and symptoms in elderly patients with ASD and restrictive LV physiology or pulmonary hypertension?
A modified fenestration technique for septal occluder devices decreases in size over time and may safely prevent acute decompensation in high-risk elderly patients undergoing ASD closure.
No takes yet. Share an insight, caveat, or question.
May support fenestrated ASD closure to avert decompensation in high-risk elderly; leaves open prospective validation in restrictive LV or PH.
Schneider et al. (2011) conducted a case report in Atrial septal defects (ASD) (n=3). Modified fenestrated Amplatzer septal occluder (ASO) was evaluated on Fenestration size, hemodynamic significance, and clinical improvement. Transcatheter closure of ASD with a modified fenestrated Amplatzer septal occluder in 3 elderly patients resulted in a trace or small fenestration without hemodynamic significance at 4-18 months.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: